Skip to content
Pharma Observatory a Scientist.com platform

Condition (MeSH)

Birth Injuries

ClinicalTrials.gov lists 47 trials for Birth Injuries or a narrower condition beneath it.

MeSH D001720 Congenital / Hereditary / Neonatal C16 C26
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Phase 1 Phase 1 1 Phase 2/3 Phase 2/3 1 Phase 3 Phase 3 2 Not applicable Not applicable 30 Observational Observational 13 Phase 1 Phase 1 1 Phase 2/3 Phase 2/3 1 Phase 3 Phase 3 2 Not applicable Not applicable 30 Observational Observational 13

Trials per phase (log scale)

33 of the 47 trials are tagged with Birth Injuries itself; the rest are tagged with a narrower condition beneath it.

Get the Birth Injuries report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

When did Birth Injuries trials start? (18)

Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Trials over time, by phase

  • Phase 1
  • Phase 2/3
  • Phase 3
  • Not applicable
  • Observational

Top of scale: 7

2002: 1 trials (Not applicable 1) 2005: 1 trials (Phase 3 1) 2006: 1 trials (Not applicable 1) 2010: 1 trials (Not applicable 1) 2012: 1 trials (Not applicable 1) 2013: 4 trials (Not applicable 4) 2015: 3 trials (Observational 2, Phase 2/3 1) 2016: 3 trials (Observational 1, Not applicable 2) 2017: 1 trials (Observational 1) 2018: 3 trials (Observational 1, Not applicable 1, Phase 3 1) 2019: 1 trials (Not applicable 1) 2020: 2 trials (Not applicable 2) 2021: 4 trials (Observational 1, Not applicable 2, Phase 1 1) 2022: 4 trials (Observational 2, Not applicable 2) 2023: 7 trials (Observational 1, Not applicable 6) 2024: 3 trials (Observational 2, Not applicable 1) 2025: 3 trials (Observational 1, Not applicable 2)

Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 4
2025 3
2024 3
2023 7
2022 4
2021 4
2020 2
2019 1
2018 3
2017 1

No forecast is made for this condition: it averages 4.4 trial starts a year over the five years to September, under the 5 a year the method needs.

Recruitment duration, a model prediction: 2 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

What phase are Birth Injuries trials in? (5)

Shown in this order: phase order.

Show the trials by phase as a table
Trials by phase
Phase Trials
Phase 1 1
Phase 2/3 1
Phase 3 2
Not applicable 30
Observational 13

How many Birth Injuries trials are recruiting? (7)

Shown in this order: the order a trial moves through, from not yet recruiting to unknown.

Trials by recruitment status
Status Trials
Not yet recruiting 4
Recruiting 4
Active, not recruiting 1
Completed 31
Terminated 2

Status as registered on ClinicalTrials.gov. Each trial is counted once.

Interventions as named in the registry (5)

Shown in this order: most trials first.

Interventions as named in the registry
Drug Trials
induction of labor 1
Routine Care 1
type A botulinum toxin 1
lidocaine 10mg/ml 1
Hydrocortisone 1% 1

These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.

Which publications cover Birth Injuries? (81)

Shown in this order: major-topic papers first, then newest, then most linked to trials.

Sub-conditions in MeSH (2)

MeSH descendants one level down with at least one trial, most trials first.

Not on this page

Not measured: delivery record.

Checked, with nothing recorded for this condition: lead sponsors, serious adverse events in this condition's trials, prevalence, and rare-disease identity.

Browse all condition evidence pages